Skip to content

Serum or Plasma Alpha-1 Antitrypsin (A1AT) Concentration

Published: August 9, 2026Updated: August 16, 2026

This test measures the level of Alpha-1 Antitrypsin, a protein produced by the liver that helps protect the lungs and other organs from damage caused by enzymes released during inflammation.

Quick summary

["Alpha-1 Antitrypsin levels help assess lung and liver health, particularly in conditions like emphysema or chronic inflammation."]

Medically reviewed by WellAlly Editorial TeamLast reviewed August 16, 2026Editorial policy

Key facts at a glance

LOINC
10049-5
Short code
S wave dur L-I
Synonyms
S wave dur L-I
Category
chemistry
Sample
serum
Container
Red-top tube (SST)
Units
N/A
Fasting
false
Population
adult
Sex
all
Age range
18–65 years
Method
ekg
Specimen volume
5 mL
Stability
Room temperature: 4h, Refrigerated: 24h, Frozen: 7d
Hemolysis max
500
Lipemia max
1000
Icterus max
500
TAT
4–24 hours
Order
routine

What Is Alpha-1 Antitrypsin?

Alpha-1 Antitrypsin (A1AT) is a protein that plays a critical role in preventing lung and liver damage. It works by neutralizing enzymes that can break down healthy tissue during inflammation. Low levels of A1AT can increase the risk of lung diseases like emphysema and liver diseases such as cirrhosis.

Why Might This Test Be Ordered?

Your healthcare provider may order this test if you have symptoms of lung problems (such as chronic coughing, shortness of breath), liver issues (like jaundice or unexplained fatigue), or a family history of A1AT deficiency. It’s also used to monitor treatment progress in certain conditions.

How Is the Test Performed?

A blood sample is drawn from a vein, usually in your arm. The blood is then processed to separate the serum or plasma, where the A1AT protein is measured using a specialized laboratory technique.

What Do Results Mean?

Results may be below, at, or above normal ranges depending on your health status. Low levels could indicate a genetic deficiency or conditions affecting liver function, while higher levels might be seen in certain inflammatory states. Your doctor will interpret results in the context of your medical history and symptoms.

Clinical interpretation

How abnormal results are interpreted and what conditions they suggest.

Clinical Significance: Alpha-1 Antitrypsin Deficiency and Related Conditions

Short name

Alpha-1 Antitrypsin

Frequently asked questions

What causes low levels of Alpha-1 Antitrypsin?
Low levels of Alpha-1 Antitrypsin can be caused by a genetic mutation (A1AT deficiency), liver disease, or chronic lung conditions. If you have a family history of lung diseases or liver problems, this test may be particularly important for early detection.
How does this test help with diagnosis?
This test helps diagnose Alpha-1 Antitrypsin deficiency, which can lead to lung diseases like emphysema or liver diseases like cirrhosis. It also helps monitor how well treatments are working for patients with these conditions.
Can lifestyle changes affect Alpha-1 Antitrypsin levels?
While lifestyle factors like smoking can worsen lung damage, they do not directly alter the level of Alpha-1 Antitrypsin. However, quitting smoking and managing other health conditions can help protect lung and liver function over time.
  1. 1
  2. 2
  3. 3

Click any link to access the full source. PubMed Central (PMC) links provide free full-text access.

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed August 16, 2026. · Read our editorial policy